Kiora Pharmaceuticals
Stock Forecast, Prediction & Price Target
Kiora Pharmaceuticals Financial Estimates
Kiora Pharmaceuticals Revenue Estimates
Kiora Pharmaceuticals EBITDA Estimates
Kiora Pharmaceuticals Earnings per Share Estimates
| Passed | Analyst forecast | ||||||
|---|---|---|---|---|---|---|---|
| Metric | 12/31/2021 | 12/31/2022 | 12/31/2023 | 12/31/2025 | 12/31/2026 | 12/31/2027 | 12/31/2028 |
Revenue
% change YoY
| $0 N/A | $0 0% | $0 0% | Avg: $2M Low: $1.96M High: $2.06M avg. 0% | Avg: $750K Low: $738.46K High: $773.07K avg. -62.5% | Avg: $28.78M Low: $28.34M High: $29.66M avg. 3737.73% | Avg: $18.68M Low: $18.39M High: $19.25M avg. -35.08% |
Net Income
% change YoY
| $-16.39M N/A | $-13.58M 17.14% | $-12.51M 7.87% | Avg: $-14.04M Low: $-1.64M High: $-1.30M avg. -12.23% | Avg: $-19.77M Low: $-1.50M High: $-871.57K avg. -40.77% | Avg: $-1.18M Low: $-1.23M High: $-1.16M avg. 93.99% | Avg: $-338.94K Low: $-352.50K High: $-332.16K avg. 71.42% |
EBITDA
% change YoY
| $-10.62M N/A | $-11.62M -9.41% | $-12.35M -6.20% | Avg: $399.99K Low: $393.84K High: $412.30K avg. 103.23% | Avg: $149.99K Low: $147.69K High: $154.61K avg. -62.50% | Avg: $5.75M Low: $5.66M High: $5.93M avg. 3737.75% | Avg: $3.73M Low: $3.67M High: $3.85M avg. -35.08% |
EPS
% change YoY
| -$68 N/A | -$18.55 72.72% | -$24.25 -30.72% | Avg: -$2.7 Low: -$3.06 High: -$2.43 avg. 88.86% | Avg: -$2.21 Low: -$2.79 High: -$1.62 avg. 18.33% | Avg: -$2.21 Low: -$2.29 High: -$2.16 avg. 0% | Avg: -$0.63 Low: -$0.66 High: -$0.62 avg. 71.42% |
Operating Expenses
% change YoY
| $10.67M N/A | $11.72M 9.86% | $12.58M 7.33% | Avg: $156.38M Low: $153.98M High: $161.20M avg. 1142.47% | Avg: $58.64M Low: $57.74M High: $60.45M avg. -62.50% | Avg: $2.25B Low: $2.21B High: $2.31B avg. 3737.73% | Avg: $1.46B Low: $1.43B High: $1.50B avg. -35.08% |
FAQ
What is Kiora Pharmaceuticals stock earnings growth forecast?
Wall Street analysts estimate the annual average earnings growth rate of 28.10% in 2025-2028.
We have gathered data from 2 analysts. Their low estimate is -1.64M, average is -14.04M and high is -1.30M.
What is Kiora Pharmaceuticals stock revenue growth forecast?
Wall Street analysts forecast annual average revenue growth of 910.03% in 2025-2028.
We have gathered data from 2 analysts. Their low revenue estimate is $1.96M, average is $2M and high is $2.06M.
What is Kiora Pharmaceuticals stock earnings per share growth forecast?
Wall Street analysts forecast annual average earnings growth of 44.65% in 2025-2028.
We have gathered data from 2 analysts. Their low earnings per share estimate is -$3.06, average is -$2.7 and high is $-2.43.